261763-32-0 Usage
Uses
Used in Pharmaceutical Industry:
Benzene, 2,3-difluoro-1-methoxy-4-methyl(9CI) is used as a key intermediate in the synthesis of pharmaceuticals for its ability to readily participate in chemical reactions, contributing to the development of new drugs and medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, Benzene, 2,3-difluoro-1-methoxy-4-methyl(9CI) serves as an essential building block in the creation of agrochemicals, aiding in the production of pesticides and other agricultural chemicals that are vital for crop protection and yield enhancement.
Used in Organic Compounds Synthesis:
Benzene, 2,3-difluoro-1-methoxy-4-methyl(9CI) is employed as a reactive component in the synthesis of a wide range of organic compounds, leveraging its reactivity to form new chemical entities with potential applications in various industries.
It is crucial to acknowledge that Benzene, 2,3-difluoro-1-methoxy-4-methyl(9CI) is considered toxic and can be harmful to human health. Therefore, stringent safety measures and precautions must be adhered to during its handling and use in any application to mitigate potential risks.
Check Digit Verification of cas no
The CAS Registry Mumber 261763-32-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,7,6 and 3 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 261763-32:
(8*2)+(7*6)+(6*1)+(5*7)+(4*6)+(3*3)+(2*3)+(1*2)=140
140 % 10 = 0
So 261763-32-0 is a valid CAS Registry Number.
261763-32-0Relevant articles and documents
PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE
-
Page/Page column 50, (2008/12/07)
The invention relates toa pharmaceutical composition comprising a pyrazole-O-glucoside derivative selected from the group of compounds (1) to (29) according to claim 1 in combination with at least one second therapeutic agent which is suitable in the trea
METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES
-
Page/Page column 36, (2010/11/25)
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for